Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares shot up 12.1% on Thursday . The company traded as high as C$0.19 and last traded at C$0.19. 109,894 shares traded hands during trading, a decline of 79% from the average session volume of 527,897 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The business’s 50-day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The firm has a market cap of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Find and Profitably Trade Stocks at 52-Week Lows
- How Value Investors Find Undervalued Stocks and Build Wealth
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- The How and Why of Investing in Gold Stocks
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
